2 news items
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada
ENDPQ
28 Mar 24
reliance on them, or any other forward-looking statements or information in this news release. Actual results may differ materially and adversely from
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
ENDPQ
26 Mar 24
to it and on assumptions it has made. Actual results may differ materially and adversely from current expectations based on a number of factors
- Prev
- 1
- Next